Temozolomide Supplier-Buyer Network — Trade Flow Analysis

Name: Temozolomide Supplier-Buyer Trade Network Dataset — 133+ Indian Exporters, 19+ Importers, 90+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Temozolomide supplier network, Temozolomide buyers, pharmaceutical export India, Temozolomide trade data

TransData Nexus

Temozolomide

India Pharmaceutical Trade Intelligence

$23.5M133 Suppliers90 CountriesHS 30049049

ExportsIndia → CANADA31.8%India → BELGIUM22.5%

ImportsBELGIUM → India$34.4K NETHERLANDS → India$30.5K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: YUSEN LOGISTICS

Who Supplies Temozolomide? Top Manufacturers & Buyers 2026 — SUN PHARMACEUTICAL INDUSTRIES LIMITED Leads | TransData Nexus | TransData Nexus

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Temozolomide exporter from India, with a market share of 36.9% and a total export value of $8.7M across 311 shipments. Their average shipment value of $27.9K is above the market average of $18.6K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $3.1M across 112 shipments (35.9% of this supplier's total exports)

• TARO PHARMACEUTICALS INC. — $3.0M across 109 shipments (35.0% of this supplier's total exports)

• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $980.0K across 35 shipments (11.3% of this supplier's total exports)

• TARO PHARMACEUTICALS INC. — $790.3K across 28 shipments (9.1% of this supplier's total exports)

• TARO PHARMACEUTICALS INC. — $760.9K across 27 shipments (8.8% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $27.9K is 50% above the market average of $18.6K, consistent with large-order contracts or value-added formulations.

2SUN PHARMACEUTICAL INDUSTRIES LTD

SUN PHARMACEUTICAL INDUSTRIES LTD is the second-largest Temozolomide exporter from India, with a market share of 8.4% and a total export value of $2.0M across 19 shipments. Their average shipment value of $103.4K is above the market average of $18.6K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TARO PHARMACEUTICALS INC. — $795.8K across 8 shipments (40.5% of this supplier's total exports)

• SUN FARMACEUTICA DO BRASIL LTD — $763.8K across 7 shipments (38.9% of this supplier's total exports)

• M S TARO PHARMACEUTI — $214.2K across 2 shipments (10.9% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $160.9K across 2 shipments (8.2% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $29.4K across 0 shipments (1.5% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LTD's per-shipment value of $103.4K is 455% above the market average of $18.6K, consistent with large-order contracts or value-added formulations.

3RELIANCE LIFE SCIENCES PRIVATE LIMITED

RELIANCE LIFE SCIENCES PRIVATE LIMITED is the third-largest Temozolomide exporter from India, with a market share of 4.8% and a total export value of $1.1M across 100 shipments. Their average shipment value of $11.3K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.

RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• DEM PHARMACEUTICALS — $471.2K across 42 shipments (41.5% of this supplier's total exports)

• JAMP PHARMA CORP — $321.0K across 28 shipments (28.3% of this supplier's total exports)

• DELTA IMPORT - EXPOR — $139.0K across 12 shipments (12.2% of this supplier's total exports)

• JAMP PHARMA CORP — $108.2K across 10 shipments (9.5% of this supplier's total exports)

• DEM PHARMACEUTICALS — $95.3K across 8 shipments (8.4% of this supplier's total exports)

Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (100 shipments) at a per-shipment value of $11.3K, indicating a broad distribution network with many smaller, regular orders.

4JODAS EXPOIM PRIVATE LIMITED

JODAS EXPOIM PRIVATE LIMITED is the fourth-largest Temozolomide exporter from India, with a market share of 4.1% and a total export value of $952.5K across 35 shipments. Their average shipment value of $27.2K is above the market average of $18.6K, suggesting premium or bulk contract pricing.

JODAS EXPOIM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• OOO"JODAS EXPOIM" — $440.9K across 16 shipments (46.3% of this supplier's total exports)

• OOO"JODAS EXPOIM" — $439.3K across 16 shipments (46.1% of this supplier's total exports)

• ZISTA PHARMA LIMITED — $40.8K across 1 shipments (4.3% of this supplier's total exports)

• OOO"JODAS EXPOIM" — $21.7K across 1 shipments (2.3% of this supplier's total exports)

• BANQUE POPULAIRE (BA — $9.9K across 0 shipments (1.0% of this supplier's total exports)

Key Insight: JODAS EXPOIM PRIVATE LIMITED's per-shipment value of $27.2K is 46% above the market average of $18.6K, consistent with large-order contracts or value-added formulations.

5INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the fifth-largest Temozolomide exporter from India, with a market share of 3.0% and a total export value of $699.7K across 49 shipments. Their average shipment value of $14.3K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• ALLIANCE PHARMA CO., LTD. — $220.7K across 15 shipments (31.5% of this supplier's total exports)

• XXCORXXHEAXXHCAXX PO — $172.8K across 12 shipments (24.7% of this supplier's total exports)

• XXCORXXNL XX XXB — $109.8K across 8 shipments (15.7% of this supplier's total exports)

• EVERSANA LIFE SCIENC — $98.5K across 7 shipments (14.1% of this supplier's total exports)

• XXCORXXHEAXXHCAXX SX — $97.8K across 7 shipments (14.0% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (49 shipments) at a per-shipment value of $14.3K, indicating a broad distribution network with many smaller, regular orders.

6ACCURE LABS PRIVATE LIMITED

ACCURE LABS PRIVATE LIMITED is the fifth-largest Temozolomide exporter from India, with a market share of 2.4% and a total export value of $554.3K across 45 shipments. Their average shipment value of $12.3K is below the market average of $18.6K, reflecting a high-volume, competitive pricing strategy.

ACCURE LABS PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• BANQUE POPULAIRE B P — $232.7K across 19 shipments (42.0% of this supplier's total exports)

• NA — $103.7K across 8 shipments (18.7% of this supplier's total exports)

• TO THE ORDER OF — $93.5K across 8 shipments (16.9% of this supplier's total exports)

• BANQUE POPULAIRE B P — $68.6K across 6 shipments (12.4% of this supplier's total exports)

• CREDIT IMMOBILIER ET — $55.8K across 5 shipments (10.1% of this supplier's total exports)

Key Insight: ACCURE LABS PRIVATE LIMITED operates with high shipment frequency (45 shipments) at a per-shipment value of $12.3K, indicating a broad distribution network with many smaller, regular orders.

1Canada

Canada ranks as the first-largest destination for Temozolomide imports from India, with a total trade value of $7.5M across 38 shipments — representing a 31.8% share of all Temozolomide exports. The average shipment value of $196.5K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Temozolomide importers in Canada: TARO PHARMACEUTICALS INC., is the largest buyer, accounting for 40.7% ($3.0M) of this market's total imports.

• TARO PHARMACEUTICALS INC., — $3.0M (40.7% of Canada's total)

• TARO PHARMACEUTICALS INC — $2.7M (36.1% of Canada's total)

• TARO PHARMACEUTICALS INC. — $760.9K (10.2% of Canada's total)

Key Insight: Canada's per-shipment average of $196.5K (954% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Temozolomide imports from India.

Primary Market

Secondary Market

2Belgium

Belgium ranks as the second-largest destination for Temozolomide imports from India, with a total trade value of $5.3M across 207 shipments — representing a 22.5% share of all Temozolomide exports. The average shipment value of $25.6K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Temozolomide importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 88.3% ($4.7M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $4.7M (88.3% of Belgium's total)

• YUSEN LOGISTICS BENELUX BELGIUM KEETBERGLAAN — $536.7K (10.1% of Belgium's total)

Key Insight: Belgium's per-shipment average of $25.6K (37% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Temozolomide imports from India.

Primary Market

Secondary Market

3Brazil

Brazil ranks as the third-largest destination for Temozolomide imports from India, with a total trade value of $2.5M across 7 shipments — representing a 10.7% share of all Temozolomide exports. The average shipment value of $359.1K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Temozolomide importers in Brazil: M/S. SUN FARMACEUTICA DO BRAZIL LTD is the largest buyer, accounting for 39.0% ($980.0K) of this market's total imports.

• M/S. SUN FARMACEUTICA DO BRAZIL LTD — $980.0K (39.0% of Brazil's total)

• SUN FARMACEUTICA DO BRASIL LTD — $763.8K (30.4% of Brazil's total)

Key Insight: Brazil's per-shipment average of $359.1K (1827% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Brazil is a key market for Temozolomide imports from India.

Primary Market

Secondary Market

4Russia

Russia ranks as the fourth-largest destination for Temozolomide imports from India, with a total trade value of $1.7M across 13 shipments — representing a 7.1% share of all Temozolomide exports. The average shipment value of $127.8K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Temozolomide importers in Russia: OOO"JODAS EXPOIM" is the largest buyer, accounting for 63.9% ($1.1M) of this market's total imports.

• OOO"JODAS EXPOIM" — $1.1M (63.9% of Russia's total)

• OOOJODAS EXPOIM — $439.3K (26.4% of Russia's total)

Key Insight: Russia's per-shipment average of $127.8K (586% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Temozolomide imports from India.

Primary Market

Secondary Market

5United States

United States ranks as the fifth-largest destination for Temozolomide imports from India, with a total trade value of $959.1K across 0 shipments — representing a 4.1% share of all Temozolomide exports. The average shipment value of $959.1K is above the global average of $18.6K, indicating high-value procurement contracts or branded formulations.

Key Insight: United States's per-shipment average of $959.1K (5046% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Temozolomide imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Temozolomide.
2.Flow Mapping: 133 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 1,261 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 90 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1,261 Verified Shipments

133 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Temozolomide

Temozolomide

Who Supplies Temozolomide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Temozolomide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Temozolomide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

2SUN PHARMACEUTICAL INDUSTRIES LTD

3RELIANCE LIFE SCIENCES PRIVATE LIMITED

4JODAS EXPOIM PRIVATE LIMITED

5INTAS PHARMACEUTICALS LIMITED

6ACCURE LABS PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Temozolomide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Temozolomide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Canada

2Belgium

3Brazil

4Russia

5United States

People Also Ask — Temozolomide Supplier & Trade Network

Temozolomide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology